Do You Suffer from Neuropathy?

Optimize Blood Circulation for Significant Outcomes!

Subjects suffering from high blood sugar have reported neuropathy pain relief minutes after D'OXYVA® (deoxyhemoglobin vasodilator) was administered and long-term blood sugar level improvements in just a few weeks.

Rapid and gentle transdermal (over the skin) delivery with the D'OXYVA light-weight and hand-held device has recorded improving the blood microcirculation or perfusion index (PI) by up to 23%* in all participants. (Measured lasting results at 5–60 minutes and up to 4 hours after single 5–minute D'OXYVA delivery on skin surface, no reduction in PI levels.)

*Average results rounded for display, based on number of enrolled subjects in each clinical study with D'OXYVA.
Request Clinical Paper

D'OXYVA is a novel, clinically validated and side effect-free solution and in various clinical trials has validated leading independent research results and demonstrated above-average results in improving a host of physiological functions at the same time.

Taking D'OXYVA daily, users have reported a number of quality of life benefits beyond significantly reducing risks of chronic conditions, including but not limited to:

    Relief from symptoms of microvascular complications

    Significantly increased cardiac function, physical fitness, endurance and strength, muscle size, body tone, faster recovery from sports injuries and surgical trauma

    Promoting and maintaining a healthy weight, improving general mobility, deeper, more restful sleep

    Significant improvement of mental acuity; concentration, problem solving, multitasking, eye-hand coordination, heightened stamina, energy, and focus while managing stress

    Improved vitals across the board during checkups with zero adverse event reports after years of regular use by people with various health, demographic, and ethnic backgrounds

Click here and learn more about how taking D'OXYVA® just a few times a week could start your new life today

  • Learn About Microcirculation
  • Clinical Research, Scientific Advisory Board, References

  • Back to Top ^

    What it does

    D'OXYVA® (deoxyhemoglobin vasodilator) is the only fully non-invasive, non-irritating, non-opioid, and completely painless, transdermal (over the skin) microcirculatory solution with industry-leading clinical research results that does not break the skin's barrier.

    In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D'OXYVA is leading the field by quickly targeting to:

    Significantly lower the risk of diabetes and cardiovascular complications

    Provide complete healing of difficult wounds together with major pain relief and improved quality of life:

    • Detoxify the skin and body
    • Improve sleep
    • Stamina and skin health
    • Reduce inflammation
    • And much more for all kinds of people

    How it works

    D'OXYVA's soft water and GMP-compliant purified medical CO2 vapor mixture readily dissolves in a molecular form in the skin to increase skin perfusion pressure, microcirculation.

    It is non-electrical, handheld, painless, fast, and easy to use with no adverse side effects, according to years of user feedback and the results of past clinical trials with D'OXYVA.

    It is an affordable, stand alone and adjunct application locally and all over the body. Taking D'OXYVA is easy; hold it against your skin surface for 5 minutes total, like comfortably inserting your thumb or anywhere you are hurt.

    Increased oxygen-rich microcirculatory tissue perfusion is widely reported in published clinical research to improve physiological processes including but not limited to wound, tissue healing and repair, athletic performance, stamina, sleep quality, skin health, and much more.

    D'OXYVA has recorded instant, outsized, and sustained improvements of the autonomic nervous system (ANS) in the brain leading to major tissue perfusion, blood circulation in macro-, and microcirculation enhancement in controlled human clinical trials (Phase I to III). These benefits result in significant improvements of essential physiological processes and clinical outcomes.

    Medical CO2 gas is a widely accepted so-called gasotransmitter acting as a natural vasodilator amongst other beneficial critical signaling funtions when delivered by D'OXYVA's patented and patent-pending process.

    D'OXYVA delivers the highest possible concentration of CO2 and has been clinically studied to significantly increase lasting blood flow volume in the microcirculatory system.

    In addition, increased microcirculation with CO2 is widely known to increase the perfusion of oxygen.

    Shop All Products

    Talk to a Representative

    Back to Top ^